Literature DB >> 6128195

Apparent intramolecular acyl migration of zomepirac glucuronide.

J Hasegawa, P C Smith, L Z Benet.   

Abstract

For the antiinflammatory drug zomepirac (Z), 5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2 acetic acid, the glucuronic acid conjugate (ZG) is the major metabolite. During analytical development ZG was found to be unstable at physiological pH, leading to four compounds other than Z. ZG and the other fractions were purified from urine by preparative HPLC and the structure of ZG was confirmed by elemental analysis and by NMR and mass spectrometry. Fast atom bombardment mass spectrometry was used to analyze the unstable, underivatized acyl glucuronides. ZG was cleaved by beta-glucuronidase but the other fractions were not. The stability of ZG was determined over a pH range of 1-8; the half-life was 27 min at pH 7.4 and 37 degrees C in water; maximum stability was found at pH 2. Intramolecular acyl migration of the glucuronide is postulated, as four of the isolated fractions formed from ZG yielded a mass-spectral parent ion corresponding to ZG+ H. The importance of sample handling prior to analysis to avoid acyl migration is emphasized.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128195

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans.

Authors:  T B Vree; E W Beneken Kolmer
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

2.  Stereoselective disposition of ibuprofen enantiomers in the isolated perfused rat kidney.

Authors:  H Y Ahn; F Jamali; S R Cox; D Kittayanond; D E Smith
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

3.  In vitro metabolism of the analgesic agent, RWJ-37874, in rat and human.

Authors:  W N Wu; L A McKown; J R Carson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Apr-Jun       Impact factor: 2.441

4.  Irreversible binding of zomepirac to plasma protein in vitro and in vivo.

Authors:  P C Smith; A F McDonagh; L Z Benet
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Interindividual variation in the capacity-limited renal glucuronidation of probenecid by humans.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster; M M Broekman
Journal:  Pharm World Sci       Date:  1993-10-15

Review 6.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

7.  Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

8.  Clearance of indomethacin occurs predominantly by renal glucuronidation.

Authors:  F Moolenaar; S Crancrinus; J Visser; D De Zeeuw; D K Meijer
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

9.  Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro.

Authors:  A Munafo; A F McDonagh; P C Smith; L Z Benet
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

10.  Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat.

Authors:  A F McDonagh; L A Palma; J J Lauff; T W Wu
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.